Bio-Gate AG (BIG) Stock Statistics & Valuation Metrics
Total Valuation
Bio-Gate AG has a market cap or net worth of EUR 4.73M. The enterprise value is ―.
- Market Cap
- EUR 4.73M
- Enterprise Value
- ―
Share Statistics
Bio-Gate AG has 2,038,738 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,038,738
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bio-Gate AG’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -643.889
- Employee Count
- 36
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Bio-Gate AG had revenue of ― and earned -23.18K in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- 2.85M
- Operating Income
- 1.09M
- Pretax Income
- ―
- Net Income
- -23.18K
- EBITDA
- 302.42K
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- -44.10%
- 50-Day Moving Average
- 2.63
- 200-Day Moving Average
- 3.04
- Relative Strength Index (RSI)
- 22.87
- Average Volume (3m)
- 975
Balance Sheet
Bio-Gate AG has ― in cash and marketable securities with EUR 139.94K in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- EUR 139.94K
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
Analyst Forecast
The average price target for Bio-Gate AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 4.92%
- EPS Growth Forecast
- 30.05%
Scores
- Smart Score
- 2
- AI Score
- ―
